JOHNSON & JOHNSON Insider Trading Activity

Average Profitability
6.16%
Insider Buys Quantity
3
Insider Buys Sum
$16.43M
Insider Sells Quantity
1
Insider Sells Sum
$96,142.25

Insider Activity of JOHNSON & JOHNSON

According to the SEC Form 4 filings, JOHNSON & JOHNSON, being in a position of

  1. 10 percent owner at CVRx, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 78569 shares for $797,482,
    over all time since 2024-02-16, has bought 0 shares, and sold 82294 shares for $893,624.

Biography of JOHNSON & JOHNSON

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $797,4827100

Comparison of Insiders on Amount of Buys and Sells

2025-11-26SaleCVRx, Inc.
CVRX
10 percent owner
6,337
0.0247%
$10.03$63,560-41.61%
2025-11-25SaleCVRx, Inc.
CVRX
10 percent owner
16,000
0.0622%
$10.03$160,480-42.54%
2025-11-24SaleCVRx, Inc.
CVRX
10 percent owner
2,200
0.0086%
$10.06$22,132-41.46%
2025-11-21SaleCVRx, Inc.
CVRX
10 percent owner
500
0.0019%
$10.00$5,000-41.32%
2025-11-12SaleCVRx, Inc.
CVRX
10 percent owner
1,000
0.0039%
$10.00$10,000-37.6%
2025-11-07SaleCVRx, Inc.
CVRX
10 percent owner
200
0.0008%
$10.00$2,000-38.83%
2025-11-06SaleCVRx, Inc.
CVRX
10 percent owner
52,332
0.2005%
$10.21$534,310-40.65%
2024-02-16SaleCVRx, Inc.
CVRX
10 percent owner
3,725
0.0203%
$25.81$96,142-47.5%
2016-08-16PurchaseProtagonist Therapeutics, Inc.
PTGX
10 percent owner
583,333
7.2004%
$12.00$7M+18.24%
2015-03-18PurchaseMinerva Neurosciences, Inc.
NERV
10 percent owner
607,903
2.4657%
$4.93$3M-14.54%
2015-03-13PurchaseMinerva Neurosciences, Inc.
NERV
10 percent owner
1.22M
6.3714%
$5.29$6.43M+2.69%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.